ACOG
Price
$5.87
Change
-$0.25 (-4.08%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
122.7M
Intraday BUY SELL Signals
ALZN
Price
$2.33
Change
-$0.01 (-0.43%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
8.86M
Intraday BUY SELL Signals
Interact to see
Advertisement

ACOG vs ALZN

Header iconACOG vs ALZN Comparison
Open Charts ACOG vs ALZNBanner chart's image
Alpha Cognition
Price$5.87
Change-$0.25 (-4.08%)
Volume$1.46K
Capitalization122.7M
Alzamend Neuro
Price$2.33
Change-$0.01 (-0.43%)
Volume$100
Capitalization8.86M
ACOG vs ALZN Comparison Chart in %
ACOG
Daily Signal:
Gain/Loss:
ALZN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ACOG vs. ALZN commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACOG is a StrongBuy and ALZN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (ACOG: $6.13 vs. ALZN: $2.33)
Brand notoriety: ACOG and ALZN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACOG: 75% vs. ALZN: 32%
Market capitalization -- ACOG: $122.7M vs. ALZN: $8.86M
ACOG [@Biotechnology] is valued at $122.7M. ALZN’s [@Biotechnology] market capitalization is $8.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACOG’s FA Score shows that 1 FA rating(s) are green whileALZN’s FA Score has 1 green FA rating(s).

  • ACOG’s FA Score: 1 green, 4 red.
  • ALZN’s FA Score: 1 green, 4 red.
According to our system of comparison, both ACOG and ALZN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACOG’s TA Score shows that 5 TA indicator(s) are bullish while ALZN’s TA Score has 4 bullish TA indicator(s).

  • ACOG’s TA Score: 5 bullish, 4 bearish.
  • ALZN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ACOG is a better buy in the short-term than ALZN.

Price Growth

ACOG (@Biotechnology) experienced а +7.54% price change this week, while ALZN (@Biotechnology) price change was -7.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.47%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +62.00%.

Industries' Descriptions

@Biotechnology (+1.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACOG($123M) has a higher market cap than ALZN($8.86M). ACOG YTD gains are higher at: 3.905 vs. ALZN (-77.586). ALZN has higher annual earnings (EBITDA): -6.17M vs. ACOG (-19.78M). ACOG has more cash in the bank: 39.4M vs. ALZN (5.62M). ALZN has less debt than ACOG: ALZN (301K) vs ACOG (2.21M). ACOG has higher revenues than ALZN: ACOG (4.59M) vs ALZN (0).
ACOGALZNACOG / ALZN
Capitalization123M8.86M1,389%
EBITDA-19.78M-6.17M321%
Gain YTD3.905-77.586-5%
P/E RatioN/AN/A-
Revenue4.59M0-
Total Cash39.4M5.62M701%
Total Debt2.21M301K736%
TECHNICAL ANALYSIS
Technical Analysis
ACOGALZN
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
71%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 24 days ago
79%
Declines
ODDS (%)
Bearish Trend 17 days ago
85%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
62%
View a ticker or compare two or three
Interact to see
Advertisement
ACOG
Daily Signal:
Gain/Loss:
ALZN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NINOY11.590.29
+2.57%
Nikon Corp.
ALFVY48.310.10
+0.20%
Alfa-Laval AB
AABVF0.02N/A
N/A
Aberdeen International Inc.
IVEVF4.44N/A
N/A
INVENTIVA SA
KENS0.15N/A
N/A
Kenilworth Systems Corp.

ACOG and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACOG has been loosely correlated with VRCA. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if ACOG jumps, then VRCA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACOG
1D Price
Change %
ACOG100%
N/A
VRCA - ACOG
35%
Loosely correlated
+4.37%
RGNX - ACOG
29%
Poorly correlated
+0.43%
CUE - ACOG
28%
Poorly correlated
-2.25%
ALZN - ACOG
27%
Poorly correlated
-0.85%
IMMX - ACOG
27%
Poorly correlated
+15.17%
More

ALZN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALZN has been loosely correlated with SRPT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ALZN jumps, then SRPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALZN
1D Price
Change %
ALZN100%
-0.85%
SRPT - ALZN
49%
Loosely correlated
+0.11%
VRAX - ALZN
46%
Loosely correlated
-1.15%
SNSE - ALZN
41%
Loosely correlated
+5.59%
ASBP - ALZN
38%
Loosely correlated
-7.66%
BPMUF - ALZN
36%
Loosely correlated
N/A
More